Patent · US Active

Diagnostic tools for response to 6-thiopurine therapy

US10385395B2 · kind B2 · utility

0Cited by
38References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 11, 2013
Grant dateAug 20, 2019
Priority date
Expiry dateApr 27, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/065
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

NK cell licensing predisposes patients to chronic inflammatory disease. Methods and kits to diagnose and treat chronic inflammatory disease based on genetic haplotype and cytokine profile are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.